Leslee Cohen-Lavin and her family were feeling pretty good just before the holidays. “Then all of a sudden, we each went down ...
Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...
Discover CDC findings on COVID-19 variants and vaccine protection, revealing key insights into emerging strains and public ...
At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...
Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...
The global response to the COVID-19 pandemic has been characterized by a massive rollout of vaccines aimed at curbing the ...
Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...
Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory ...